Hip replacement: which surgical path spares your muscles?
NCT ID NCT07851597
First seen Oct 01, 2026 · Last updated Oct 02, 2026 · Updated 1 time
Summary
Researchers compare two common surgical approaches for total hip replacement to see how the hip's muscles and tendons heal afterward. Forty people with hip osteoarthritis having cemented hip replacement take part. The team marks detached tendons with tiny metal beads, tracks their movement with imaging, and measures hip strength over time. They also interview patients about their recovery experience.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Total hip arthroplasty using either a direct lateral or posterolateral surgical approach, with tendon markers tracked by imaging
- What this could lead to
- If one approach helps hip muscles heal better, surgeons could choose it to give patients stronger recovery and fewer long-term walking problems.
- What could go wrong
- This is a small study of 40 people at one hospital, so its findings may not apply to everyone. Hip replacement itself carries risks like infection, blood clots, and nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2021
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * hip osteoarthritis as indication for THA surgery * use of cemented prosthetic Components Exclusion Criteria: * symptomatic osteoarthritis on the contralateral hip * neuromuscular disorder * dementia * BMI\>40 * previous surgery on any hip
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip arthroplasty are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Gävle hospital orthopaedic clinic
RECRUITINGGävle, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI read your movement? smartphone video tested as Stand-In for clinic exams
- Can a handgrip test predict how well you recover from joint replacement surgery?
- Can a new drug quiet opioid withdrawal without sacrificing pain relief?
- A neck artery scan may reveal who will drop blood pressure during hip surgery
- Can hip or knee replacement surgery trigger Alzheimer's-Linked tau buildup?
- Can a cementless hip implant last? study tracks the SMS femoral stem